Adam Koppel, 10% Owner, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 1,450,000 shares at $71.50 ($103.7M) on 2021-03-09, disclosed to the SEC on 2021-03-11.
Open-market sale of $103.7M SWTX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |
| CERE | BUY | 2020-10-29 | $100.0M | — | Filing → |